A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Liu, Chih-Pin, Ph.D. Research Bookmark and Share

Chih-Pin Liu, Ph.D. Research

T-cells and Immunity
T-cells play a central role in the generation of the host’s immunity to infections and tumors, and in the regulation of autoimmunity and allergy.  A critical prerequisite for selection and maturation of T-cells is cell surface expression of the T-cell antigen receptor (TCR) complex, which is responsible for recognition of antigens and for transmitting signals inside the cell. These processes are regulated by the interaction of TCR with antigens presented by major histocompatibility complex (MHC) molecules expressed on antigen presenting cells. Research carried out in this laboratory investigates the molecular and cellular mechanisms underlying T-cell mediated immunity against tumors and the roles of T-cells in regulating inflammatory and autoimmune diseases.

Mechanisms underlying T-cell-mediated Immunity
Recognition of the MHC/antigen complex by TCRs generates a series of signaling events that regulate the behavior and function of T-cells. To study the molecular and cellular mechanisms regulating T-cell mediated immunity, we will use state-of-art molecular and proteomics (the study of proteins) approaches to identify the molecules regulating the activation and apoptosis of normal T cells and T cell leukemia. We will also investigate the in vivo role of these molecules using transgenic and gene knockout mice. These proteins may serve as molecular targets for modulating the function of T-cells and for the further immunotherapeutic treatment of various types of cancers. Moreover, we will perform experiments to determine the mechanisms that regulate T-cell functions responsible for tumor immunity and autoimmunity.

Regulation of Autoimmune Disease
In autoimmune diseases, such as type 1 diabetes, presentation of autoantigens by disease-associated MHC plays a critical role in the selection and activation of disease-associated T-cells.  It is now known that T-cells not only function as pathogenic T-cells that cause the disease but also function as regulatory T-cells that inhibit the disease. It has been shown that antigen-specific regulatory T-cells are more potent than a heterogeneous population of regulatory T cells in suppressing pathogenic processes. Therefore, it is desirable to use antigen-specific regulatory T cells to modulate the function of pathogenic T-cells to prevent autoimmune disease. It has been historically very difficult for immunologists to identify and isolate a sufficient number of antigen-specific T cells for further studies. We have addressed this question using novel multivalent MHC/ antigen tetramers, and have identified and isolated several lines of antigen-specific regulatory T-cells. We have demonstrated that the isolated regulatory T-cells can effectively inhibit type 1 diabetes.  Based on these findings, we will investigate the molecular and cellular mechanisms underlying the regulation of pathogenic T cell by these regulatory T cells that lead to prevention of the disease.  We will also examine whether these potent regulatory T cells can be used as a treatment to prevent the immune destruction of islet grafts in an animal model for islet transplantation.
 

Chih-Pin Liu, Ph.D. Lab Members

Chih-Pin Liu, Ph.D.
Professor
626-256-HOPE (4673),ext. 63455

Weiting Du, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 63427

Jiangying Shen, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 6037

Ding Wang, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 65254

Wenhui Lee, M.S.
Senior Research Associate
Research Associate
626-256-HOPE (4673),ext. 65525

Yueh-Wei Shen
Research Associate II
626-256-HOPE (4673),ext. 65520

Liu, Chih-Pin, Ph.D. Research

Chih-Pin Liu, Ph.D. Research

T-cells and Immunity
T-cells play a central role in the generation of the host’s immunity to infections and tumors, and in the regulation of autoimmunity and allergy.  A critical prerequisite for selection and maturation of T-cells is cell surface expression of the T-cell antigen receptor (TCR) complex, which is responsible for recognition of antigens and for transmitting signals inside the cell. These processes are regulated by the interaction of TCR with antigens presented by major histocompatibility complex (MHC) molecules expressed on antigen presenting cells. Research carried out in this laboratory investigates the molecular and cellular mechanisms underlying T-cell mediated immunity against tumors and the roles of T-cells in regulating inflammatory and autoimmune diseases.

Mechanisms underlying T-cell-mediated Immunity
Recognition of the MHC/antigen complex by TCRs generates a series of signaling events that regulate the behavior and function of T-cells. To study the molecular and cellular mechanisms regulating T-cell mediated immunity, we will use state-of-art molecular and proteomics (the study of proteins) approaches to identify the molecules regulating the activation and apoptosis of normal T cells and T cell leukemia. We will also investigate the in vivo role of these molecules using transgenic and gene knockout mice. These proteins may serve as molecular targets for modulating the function of T-cells and for the further immunotherapeutic treatment of various types of cancers. Moreover, we will perform experiments to determine the mechanisms that regulate T-cell functions responsible for tumor immunity and autoimmunity.

Regulation of Autoimmune Disease
In autoimmune diseases, such as type 1 diabetes, presentation of autoantigens by disease-associated MHC plays a critical role in the selection and activation of disease-associated T-cells.  It is now known that T-cells not only function as pathogenic T-cells that cause the disease but also function as regulatory T-cells that inhibit the disease. It has been shown that antigen-specific regulatory T-cells are more potent than a heterogeneous population of regulatory T cells in suppressing pathogenic processes. Therefore, it is desirable to use antigen-specific regulatory T cells to modulate the function of pathogenic T-cells to prevent autoimmune disease. It has been historically very difficult for immunologists to identify and isolate a sufficient number of antigen-specific T cells for further studies. We have addressed this question using novel multivalent MHC/ antigen tetramers, and have identified and isolated several lines of antigen-specific regulatory T-cells. We have demonstrated that the isolated regulatory T-cells can effectively inhibit type 1 diabetes.  Based on these findings, we will investigate the molecular and cellular mechanisms underlying the regulation of pathogenic T cell by these regulatory T cells that lead to prevention of the disease.  We will also examine whether these potent regulatory T cells can be used as a treatment to prevent the immune destruction of islet grafts in an animal model for islet transplantation.
 

Lab Members

Chih-Pin Liu, Ph.D. Lab Members

Chih-Pin Liu, Ph.D.
Professor
626-256-HOPE (4673),ext. 63455

Weiting Du, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 63427

Jiangying Shen, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 6037

Ding Wang, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 65254

Wenhui Lee, M.S.
Senior Research Associate
Research Associate
626-256-HOPE (4673),ext. 65525

Yueh-Wei Shen
Research Associate II
626-256-HOPE (4673),ext. 65520
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
NEWS & UPDATES
  • Although chemotherapy can be effective in treating cancer, it can also exact a heavy toll on a patient’s health. One impressive alternative researchers have found is in the form of a vaccine. A type of immunotherapy, one part of the vaccine primes the body to react strongly against a tumor; the second part dire...
  • The breast cancer statistic is attention-getting: One in eight women will be diagnosed with breast cancer during her lifetime. That doesn’t mean that, if you’re one of eight women at a dinner table, one of you is fated to have breast cancer (read more on that breast cancer statistic), but it does mean that the ...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. In his first post, ...
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...
  • The leading risk factor for breast cancer is simply being a woman. The second top risk factor is getting older. Obviously, these two factors cannot be controlled, which is why all women should be aware of their risk and how to minimize those risks. Many risk factors can be mitigated, and simple changes can lead...
  • All women are at some risk of developing the disease in their lifetimes, but breast cancer, like other cancers, has a disproportionate effect on minorities. Although white women have the highest incidence of breast cancer, African-American women have the highest breast cancer death rates of all racial and ethni...
  • First, the good news: HIV infections have dropped dramatically over the past 30 years. Doctors, researchers and health officials have made great strides in preventing and treating the disease, turning what was once a death sentence into, for some, a chronic condition. Now, the reality check: HIV is still a worl...
  • Screening for breast cancer has dramatically increased the number of cancers found before they cause symptoms – catching the disease when it is most treatable and curable. Mammograms, however, are not infallible. It’s important to conduct self-exams, and know the signs and symptoms that should be checked by a h...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free.   In his previ...
  • In a single day, former professional triathlete Lisa Birk learned she couldn’t have children and that she had breast cancer. “Where do you go from there?” she asks. For Birk, who swims three miles, runs 10 miles and cycles every day, the answer  ultimately was a decision to take control of her cancer care. Afte...
  • More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools. Today there are nearly 14.5 million cancer survivors in the United States. But in up to 20 percent of cancer patients, the disease ultimately spreads to their brain. Each year, nearly 170,000 new cases of brain ...